Oregon Public Employees Retirement Fund lifted its position in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 33.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 52,005 shares of the real estate investment trust’s stock after purchasing an additional 13,040 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Ventas were worth $3,640,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the company. True Wealth Design LLC grew its stake in Ventas by 1,557.7% during the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 405 shares during the last quarter. Ameritas Advisory Services LLC purchased a new stake in Ventas in the second quarter valued at approximately $33,000. Golden State Wealth Management LLC boosted its holdings in shares of Ventas by 52.7% in the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 185 shares during the period. Elevation Point Wealth Partners LLC purchased a new position in shares of Ventas during the second quarter worth approximately $35,000. Finally, IFP Advisors Inc grew its position in shares of Ventas by 61.3% during the second quarter. IFP Advisors Inc now owns 974 shares of the real estate investment trust’s stock worth $62,000 after acquiring an additional 370 shares during the last quarter. 94.18% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. Weiss Ratings upgraded shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. The Goldman Sachs Group initiated coverage on shares of Ventas in a report on Friday. They issued a “buy” rating and a $94.00 target price for the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $93.00 target price on shares of Ventas in a research note on Monday, January 5th. Wells Fargo & Company raised their price target on Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, UBS Group began coverage on Ventas in a research report on Friday, September 19th. They issued a “neutral” rating and a $73.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.65.
Insider Activity
In other Ventas news, CEO Peter J. Bulgarelli sold 2,229 shares of the stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $80.08, for a total value of $178,498.32. Following the completion of the transaction, the chief executive officer directly owned 106,488 shares of the company’s stock, valued at approximately $8,527,559.04. This trade represents a 2.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the sale, the chief financial officer owned 138,434 shares of the company’s stock, valued at approximately $10,694,026.50. The trade was a 17.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 713,520 shares of company stock valued at $52,788,577 in the last three months. 1.00% of the stock is currently owned by company insiders.
Ventas Stock Down 0.2%
Shares of Ventas stock opened at $74.90 on Monday. Ventas, Inc. has a one year low of $56.97 and a one year high of $81.89. The company has a market cap of $35.18 billion, a P/E ratio of 144.05, a PEG ratio of 1.85 and a beta of 0.78. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.32 and a current ratio of 0.32. The firm has a fifty day moving average of $78.25 and a two-hundred day moving average of $71.42.
Ventas (NYSE:VTR – Get Free Report) last issued its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.01. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.44 billion. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The business’s revenue was up 20.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.80 earnings per share. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. On average, analysts forecast that Ventas, Inc. will post 3.4 earnings per share for the current year.
Ventas Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be paid a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Wednesday, December 31st. Ventas’s dividend payout ratio is 369.23%.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Huge robotics rollout underway
- Do not delete, read immediately
- Free: The Crypto Summit That Could Change Your Life
- Trump Planning to Use Public Law 63-43: Prepare Now
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
